STOCKS IN THIS WATCHLIST ARE GENERALLY GEARED TOWARDS SWING TRADING BUT CAN ALSO BE USED FOR DAY OR LONG TRADES. STOCKS ARE EITHER TRENDING TOWARDS A BULLISH TECHNICAL CHART OR CURRENTLY IN ONE. ANY TECHNICAL ANALYSIS IS PROVIDED IN THE ACCOMPANYING CHARTS. PLEASE DO YOUR OWN DUE DILIGENCE BEFORE INVESTING IN THESE STOCKS. (The Shares Float is based on figures from FinViz.Com or wsj.com).
Stocks highlighted in this watchlist include: $BTCS, $BTSC, $TLGT
BTCS: Float of 89.47M shares.
BlockChain related Investments had a major price increase on Friday. Over the weekend, Bitcoin surged from $8,300 on November 23rd to $9,725 at the time of writing this watch list. An increase of 17%. I’m expecting BTCS to rocket far higher than 17% on Monday with a continuation the rest of the week. Note the stock price crossed all major resistance points on Friday.
The total market capitalization for the cryptocurrency market has exceeded $300 billion for the first time. Data from CoinMarketCap.com shows that the market capitalization for all cryptocurrencies is currently at roughly $300.5bn. Of that amount, bitcoin's market cap represents the lion's share, accounting for about $158 billion. The move comes as the price of bitcoin continues its surge above $9,000, trading at roughly $9,482, according to the CoinDesk Bitcoin Price Index (BPI). The push above $300 billion perhaps also showcases the pace at which the market has grown in recent weeks. On Nov. 3rd, the overall market capitalization rose above $200 billion for the first time. By contrast, the market crossed the $100 billion level back in June. Other cryptocurrency market developments contributed to today's market capitalization milestone, additional data reveals. The world's second-largest cryptocurrency, ethereum, has a press-time market capitalization of $46 billion and is currently trading at about $475, representing a price increase of more than 25% in the past week. Like bitcoin, ethereum also hit a new all-time high over the weekend.
BTSC: Float of 7 billion shares. See comments under BTCS above.
TLGT: Float of 53.02 million shares with 15.98% short.
On November 22nd, the company announced it has received approval of the Company’s abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FDA) of Hydrocortisone Butyrate Lotion 0.1%. This is Teligent’s ninth approval for 2017, and its nineteenth approval from its internally-developed pipeline of topical generic pharmaceutical medicines. Based on recent QuintilesIMS Health data from September 2017, the total addressable market for this product is approximately $17.0 million.